Under Armour Inc (NYSE:UAA) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 38,647,400 shares, a growth of 19.7% from the May 30th total of 32,273,600 shares. Currently, 20.7% of the company’s stock are short sold. Based on an average daily volume of 4,760,000 shares, the days-to-cover ratio is currently 8.1 days.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Xact Kapitalforvaltning AB boosted its stake in Under Armour by 27.1% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 34,467 shares of the company’s stock valued at $874,000 after purchasing an additional 7,343 shares during the period. Patten & Patten Inc. TN bought a new stake in Under Armour in the 2nd quarter valued at $319,000. Horizon Investments LLC bought a new stake in Under Armour in the 1st quarter valued at $203,000. Gilder Gagnon Howe & Co. LLC boosted its stake in Under Armour by 4.0% in the 1st quarter. Gilder Gagnon Howe & Co. LLC now owns 9,920 shares of the company’s stock valued at $210,000 after purchasing an additional 379 shares during the period. Finally, Cerebellum GP LLC bought a new stake in Under Armour in the 1st quarter valued at $304,000. Institutional investors and hedge funds own 37.95% of the company’s stock.
Several research analysts have weighed in on UAA shares. Zacks Investment Research lowered Haynes International from a “hold” rating to a “sell” rating in a research report on Wednesday, May 8th. Credit Suisse Group raised ConocoPhillips from a “neutral” rating to an “outperform” rating and set a $75.00 price target on the stock in a research report on Tuesday, April 30th. ValuEngine lowered Intersect ENT from a “buy” rating to a “hold” rating in a research report on Monday, July 8th. Citigroup initiated coverage on Dicks Sporting Goods in a research report on Wednesday, April 10th. They set a “neutral” rating and a $40.00 price target on the stock. Finally, JPMorgan Chase & Co. set a $195.00 target price on bluebird bio and gave the stock a “buy” rating in a research note on Friday, May 17th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $23.53.
Shares of NYSE UAA opened at $27.30 on Monday. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.02 and a quick ratio of 1.22. Under Armour has a 12 month low of $16.52 and a 12 month high of $27.56. The business’s 50 day simple moving average is $25.45. The company has a market cap of $12.31 billion, a P/E ratio of 101.11, a P/E/G ratio of 2.90 and a beta of 0.47.
Under Armour (NYSE:UAA) last issued its earnings results on Thursday, May 2nd. The company reported $0.05 EPS for the quarter. Under Armour had a return on equity of 7.17% and a net margin of 0.12%. The company had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.18 billion. Under Armour’s quarterly revenue was up 1.6% compared to the same quarter last year. On average, equities analysts predict that Under Armour will post 0.35 EPS for the current fiscal year.
About Under Armour
Under Armour, Inc, together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot and cold.
Receive News & Ratings for Under Armour Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Under Armour and related companies with MarketBeat.com's FREE daily email newsletter.